|
||||||||||||
 |
||||||||||||
|
||||||||||||
Top Stories
Immunize.org Pages and Handouts
Featured Resources
Notable Publications
Global News
Top Stories
National Influenza Vaccination Week is December 5–9. Encourage vaccination as this early influenza season disrupts holiday gatherings.
National Influenza Vaccination Week (NIVW), observed December 5–9 this year, was established by CDC in 2005 to highlight the importance of continuing influenza vaccination activities throughout the holiday season and beyond. NIVW is a great time to send reminder messages and vaccinate all those who are not yet protected. Early seasonal influenza activity makes it urgent for you, your patients, and your loved ones to be vaccinated against influenza.
Register for December 13 webinar! Immunize.org with experts from the Autism Society present “Improving the Vaccination Experience: Accessible Vaccination for Neurodiverse People at Any Age.” People with autism and other developmental disabilities have lower childhood immunization rates than their peers without autism, leaving them vulnerable to many vaccine-preventable diseases. The vaccination visit can be especially stressful for these families. Effective strategies exist to reduce pain and anxiety during the vaccination visit.
After the presentation, time is reserved for your questions. Back to top
Immunize.org updates its “Vaccines: COVID-19” web page with CDC resources on bivalent booster doses for children age 5–11 and two new wall charts from FDA Immunize.org updated its Vaccines: COVID-19 main page to incorporate CDC information on bivalent booster doses for children age 5–11 and to add two new vaccine presentation charts from FDA. Related Links
In this week’s Spotlight, we summarize resources at Immunize.org that focus on the history of vaccines. These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
Back to top
Immunize.org Pages and Handouts
Seven translations of Immunize.org’s popular handout Immunizations for Babies are now available for healthcare providers to print and use. Translations include:  Immunize.org’s most recent update to “Immunizations for Babies” incorporates recommendations for COVID-19 vaccination for infants beginning at age 6 months. Related Links
Immunize.org posts seven translations of its parent handout “When Do Children and Teens Need Vaccinations?”
Seven translations of Immunize.org’s popular handout When Do Children and Teens Need Vaccinations? are now available for healthcare providers to print and use. Translations include:
Related Links
Spanish translations of Immunize.org's popular handouts, Human Papillomavirus (HPV): A Parent’s Guide to Preteen and Teen HPV Vaccination (English version) and You’re 16 . . . We Recommend These Vaccines for You! (English version), are now available for healthcare providers to print and use. Related Links
Featured Resources
Public Health Foundation and CDC release video explaining ACIP and how United States vaccine recommendations are made
The Public Health Foundation (PHF), in partnership with CDC, released an educational video titled Understanding the ACIP and How Vaccine Recommendations are Made in the U.S. The 5-minute video explains the Advisory Committee on Immunization Practices' (ACIP) role in and process for developing vaccine recommendations. The video equips clinicians with information to make approved ACIP recommendations standards of care in their own clinical practice and to engage with patients and families about vaccination. These discussions can build understanding and confidence among patients while countering miscommunication around vaccine effectiveness and safety. Great gift idea! Immunize.org's elegantly designed "Vaccines Save Lives" black enamel pins make wonderful holiday gifts or workplace recognitions. Immunize.org’s elegantly designed “Vaccines Save Lives” pins are meaningful gifts for people who care about vaccination. The pin makes a refined statement in hard black enamel with gold lettering and edges, measuring 1.125" x 0.75". Notable Publications
“Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection—Increasing Community Access to Testing Program, United States, September–November 2022” published in MMWR Early Release
CDC published Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection—Increasing Community Access to Testing Program, United States, September–November 2022 on November 22 in MMWR Early Release. A portion of the summary appears below. Monovalent mRNA COVID-19 vaccines were less effective against symptomatic infection during the period of SARS-CoV-2 Omicron variant predominance. . . . In this study of vaccine effectiveness of the U.S.-authorized bivalent mRNA booster formulations, bivalent boosters provided significant additional protection against symptomatic SARS-CoV-2 infection in persons who had previously received 2, 3, or 4 monovalent vaccine doses. Due to waning immunity of monovalent doses, the benefit of the bivalent booster increased with time since receipt of the most recent monovalent vaccine dose. . . . All persons should stay up to date with recommended COVID-19 vaccinations, including bivalent booster doses for eligible persons.
Back to top
“Analysis of COVID-19 Vaccination Status among Parents of Hospitalized Children Younger than 5 Years with SARS-CoV-2 Infection during the Delta and Omicron Waves” published in JAMA In the November 16 issue, JAMA published Analysis of COVID-19 Vaccination Status among Parents of Hospitalized Children Younger Than 5 Years With SARS-CoV-2 Infection during the Delta and Omicron Waves. A portion of the discussion section appears below. During both the Delta and Omicron periods, parents’ vaccination status was associated with a reduced risk of hospital admission for SARS-CoV-2 in children younger than 5 years. A study performed before the Omicron wave showed an association of parent vaccination with a reduced risk of SARS-CoV-2 infection in children, with lower odds ratios likely due to older children in the sample. The association between parent vaccination and reduced risk of admission for SARS-CoV-2 in children younger than 5 years suggests that parents played a major role in transmitting SARS-CoV-2 to their young children during both waves, but the association between protection and vaccination seemed lower in the Omicron vs Delta period. The Omicron variant has been shown to be more transmissible, and the [monovalent] vaccine effectiveness against infection seems lower. Global News CDC published Progress toward Regional Measles Elimination Worldwide 2000–2021 on November 23 in MMWR. A portion of the summary appears below. Progress toward measles elimination experienced setbacks in 2020 during the COVID-19 pandemic. ... During 2000–2021, measles vaccination prevented an estimated 56 million deaths worldwide. In 2021, only 81% of children received their first dose of measles containing vaccine (MCV), the lowest coverage reported since 2008, leaving 25 million children vulnerable to measles. Measles surveillance continues to be suboptimal, and large and disruptive outbreaks were reported in 22 countries. ... Reaching all children with 2 doses of MCV and strengthening measles surveillance is critical to close immunity gaps, prevent outbreaks, and recover progress lost during the pandemic.
For more upcoming events, visit our Calendar of Events. |
||||||||||||
|
